Learning Objectives: Understand the characteristics of a new software program to calculate return on investment from tobacco control programs.
Abstract: This presentation demonstrates a new sophisticated, scientifically sound, yet easy to use calculation method to quickly determine return on investment (ROI) and conduct sensitivity analysis on smoking prevention and cessation interventions in a managed care setting.
Blue Cross and Blue Shield of Minnesota teamed with Medical Scientists, Inc. of Boston, MA to develop software based on Medical Scientists’ existing MediSave software platform. MediSave is a state-of-the-art model to calculate ROI for disease management interventions, and is used in many settings for calculating ROI for heart disease, lung cancer and asthma disease management programs. Adapting MediSave to tobacco prevention and cessation programs required substantial changes, in part because tobacco is a root cause of many diseases, all of which require analysis in a ROI calculation. The basic assumptions of the Markov model on which this software model is based were presented at the 2002 ATMC conference and will be reviewed briefly here. This presentation will include a live demonstration of the MediSave software.
Back to Return on Investment: Analyzing the Impact of Your Tobacco Control Efforts
Back to Evaluation and Surveillance
Back to The 2002 National Conference on Tobacco or Health